The proteins are part of a newly discovered complex that mends genetic damage exclusively in neurons.

The research community was abuzz this week with chatter about Nature’s new policy on registered reports, a 3D genome atlas of the cerebellum, and a study that measured brain activity in freely moving octopuses.

Mice and rats, for example, gravitate toward their mother’s bedding over bedding that is clean or smells of a different dam.

The U.S. Food and Drug Administration plans to make an approval decision on the first-ever drug for girls and women with Rett syndrome by 12 March.

This month’s newsletter takes a close look at the orphan drug program in the United States, several cannabis-based therapies and a secondary analysis of bumetanide, among other new developments in autism-related drug trials.

The OTUD7A gene, which may account for some traits in people missing a segment of chromosome 15, appears to interact with several known autism-linked genes.

This week, researchers on Twitter discussed false results in gene expression studies, a wearable neuron-recording device, and paper-publishing requirements.

The “It Takes All Kinds of Minds” conference draws neurodiversity researchers, clinicians and community members to Scotland, where they plan to discuss interdisciplinary, transdiagnostic work.

After a year of intense growth, funding for biotech is in decline. The result is layoffs and program cuts — and maybe some innovation.

Early treatment with nutritional supplements and a high-protein diet forestalls some neurodevelopmental problems for children with BCKDK deficiency.